Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/2486
Title: | Metformin and Dichloroacetate Combination Exert a Synergistic Effect on Cell Viability of Oral Squamous Cell Carcinoma | Authors: | Inanc, Seniz Keles, Didem Eskiizmir, Gorkem Basbinar, Yasemin Oktay, Gulgun |
Keywords: | Metformin Dichloroacetate drug combinations oral cavity cancer Tumor-Growth Cancer Death Proliferation Hif-1-Alpha |
Publisher: | Deomed Publ, Istanbul | Abstract: | Objective: To assess the effects of Metformin, Dichloroacetate (DCA) and their combination on cell viability in oral squamous cell carcinoma, UPCI-SCC-131 cell line. Methods: UPCI-SCC-131 cells were plated in 96 E-plate (1x104 cells/well) and were treated with Metformin (1-16mM) and/or DCA (15-120mM) for 24-48-72h. xCELLigence SP system was used to monitor real time cell viability. In addition, drug combination index was analyzed with CompuSyn software according to Chou-Talalay method. Results: Half-maximal inhibitory concentrations (IC50) of Metformin and DCA were found to be 3mM and 23mM, respectively, for 72 hours. CI values (0.76-0.80) in all combination groups below 1 indicated that Metformin/DCA combination had a moderate synergistic effect on cell viability in UPCI-SCC-131 cells. Discussion: Metformin/DCA combination synergistically decreased the cell viability of UPCI-SCC-131 cells. Therefore, a combined application of Metformin and DCA may be considered as a candidate therapy for the drug repositioning of the treatment of oral cavity cancer. | URI: | https://doi.org/10.32448/entupdates.569464 https://hdl.handle.net/20.500.14365/2486 |
ISSN: | 2149-7109 2149-6498 |
Appears in Collections: | WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
WEB OF SCIENCETM
Citations
2
checked on Dec 18, 2024
Page view(s)
180
checked on Dec 16, 2024
Download(s)
30
checked on Dec 16, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.